Bryn Mawr Trust Advisors LLC raised its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,673 shares of the company’s stock after buying an additional 3,209 shares during […]